Boosting US Antibiotic Production and Stockpiling Essential Drugs
This act aims to increase the production of critical antibiotics within the United States to ensure their constant availability for patients. Through this program, the government will support companies manufacturing these drugs domestically, reducing the risk of shortages. Additionally, the act provides for the creation of national stockpiles of these important medications.
Key points
The US government will allocate $500 million to support companies producing essential antibiotics within the United States.
Companies will receive grants to expand, upgrade, or build new antibiotic manufacturing facilities in the US.
The act allows for the purchase and stockpiling of domestically produced antibiotics, enhancing drug security.
A study will be conducted to identify which antibiotics are most crucial for US production and how this will affect consumer prices.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.